Home › MannKind's loss narrows; pursues new drug candidates
 

Keywords :   


MannKind's loss narrows; pursues new drug candidates

2015-08-11 09:35:05| Biotech - Topix.net

Shares of MannKind rose on Monday after the drugmaker surpassed Wall Street's estimates for second quarter earnings and indicated several new drugs are in the company's development pipeline. Hakan S. Edstrom , president and CEO of the California-based drug company that has its manufacturing facility and pharmaceutical development operations in Danbury, said during a conference call with investors Monday that feasibility studies are being conducted on at least two new drug candidates including treatments for pain and pulmonary hypertension, a type of high blood pressure that affects arteries in the lungs and heart.

Tags: loss drug candidates narrows

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
29.09Atlantic Tropical Weather Outlook
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
More »